Nutriband Inc. Reports Revenue Up 113% YoY in Q2

ORLANDO, FL / ACCESSWIRE / September 8, 2022 / Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, today announced financial and operational results for the second quarter

Related Keywords

China ,Mexico ,Australia ,Japan ,United States ,Canada ,Russia ,Gareth Sheridan ,Company Active Intelligence ,Drug Administration ,Company Pocono Pharmaceuticals ,Nasdaq ,Exchange Commission ,Company Form ,Pocono Pharmaceuticals ,Nutriband Inc ,Health Advances ,Redchip Companies ,Company Aversa ,Aversa Fentanyl ,Private Securities Litigation Reform Act ,Federal Food ,Financial Condition ,Nutriband ,Reports ,Revenue ,